Debbie Benner1, Steven M Brunelli2, Becky Brosch3, Jane Wheeler3, Allen R Nissenson4. 1. DaVita Inc, Denver, Colorado. Electronic address: debbie.benner@davita.com. 2. DaVita Clinical Research, Minneapolis, Minnesota. 3. DaVita Inc, Denver, Colorado. 4. DaVita Inc, Denver, Colorado; David Geffen School of Medicine, University of California, Los Angeles, California.
Abstract
OBJECTIVE: Protein-energy wasting is common in end-stage renal disease patients undergoing dialysis and is strongly associated with mortality and adverse outcomes. Intradialytic oral nutritional supplements (ONS) reduce risk of mortality in these patients. Large studies characterizing the impact of ONS on other outcomes are lacking. We assessed the associations between administration of ONS and clinical and nutritional outcomes. DESIGN: Retrospective evaluation of a pilot program providing ONS to patients at a large dialysis organization in the United States. The pilot program provided ONS to in-center hemodialysis patients with serum albumin ≤3.5 g/dL at 408 facilities. SUBJECTS: ONS patients were compared to matched controls with serum albumin ≤3.5 g/dL, identified from facilities not participating in the ONS program (n = 3,374 per group). INTERVENTION: Receipt of ONS. MAIN OUTCOME MEASURES: Death, missed dialysis treatments, hospitalizations, serum albumin, normalized protein catabolic rate, and postdialysis body weight were abstracted from large dialysis organization electronic medical records. RESULTS: There was a 69% reduction in deaths (hazard ratio = 0.31; 95% confidence interval = 0.25-0.39), and 33% fewer missed dialysis treatments (incidence rate ratio = 0.77; 95% confidence interval = 0.73-0.82) among ONS patients compared to controls (P < .001 for both). The effects of ONS on nutritional indices were mixed: serum albumin was lower, whereas normalized protein catabolic rate values, a surrogate for dietary protein intake, and postdialysis body weights were higher for ONS patients compared to controls during follow-up. CONCLUSIONS: Our evaluation confirmed the beneficial effects of ONS in reducing mortality and improving some indices of nutritional status for hypoalbuminemic hemodialysis patients. We also report the novel finding that ONS can reduce the number of missed dialysis treatments. These results support the use of intradialytic ONS as an effective intervention to improve the outcomes in hemodialysis patients with low serum albumin.
OBJECTIVE: Protein-energy wasting is common in end-stage renal diseasepatients undergoing dialysis and is strongly associated with mortality and adverse outcomes. Intradialytic oral nutritional supplements (ONS) reduce risk of mortality in these patients. Large studies characterizing the impact of ONS on other outcomes are lacking. We assessed the associations between administration of ONS and clinical and nutritional outcomes. DESIGN: Retrospective evaluation of a pilot program providing ONS to patients at a large dialysis organization in the United States. The pilot program provided ONS to in-center hemodialysis patients with serum albumin ≤3.5 g/dL at 408 facilities. SUBJECTS:ONSpatients were compared to matched controls with serum albumin ≤3.5 g/dL, identified from facilities not participating in the ONS program (n = 3,374 per group). INTERVENTION: Receipt of ONS. MAIN OUTCOME MEASURES: Death, missed dialysis treatments, hospitalizations, serum albumin, normalized protein catabolic rate, and postdialysis body weight were abstracted from large dialysis organization electronic medical records. RESULTS: There was a 69% reduction in deaths (hazard ratio = 0.31; 95% confidence interval = 0.25-0.39), and 33% fewer missed dialysis treatments (incidence rate ratio = 0.77; 95% confidence interval = 0.73-0.82) among ONSpatients compared to controls (P < .001 for both). The effects of ONS on nutritional indices were mixed: serum albumin was lower, whereas normalized protein catabolic rate values, a surrogate for dietary protein intake, and postdialysis body weights were higher for ONSpatients compared to controls during follow-up. CONCLUSIONS: Our evaluation confirmed the beneficial effects of ONS in reducing mortality and improving some indices of nutritional status for hypoalbuminemic hemodialysis patients. We also report the novel finding that ONS can reduce the number of missed dialysis treatments. These results support the use of intradialytic ONS as an effective intervention to improve the outcomes in hemodialysis patients with low serum albumin.
Authors: Jin Hee Jeong; Annabel Biruete; Emily J Tomayko; Pei Tzu Wu; Peter Fitschen; Hae Ryong Chung; Mohamad Ali; Edward McAuley; Bo Fernhall; Shane A Phillips; Kenneth R Wilund Journal: Kidney Int Date: 2019-04-02 Impact factor: 10.612
Authors: Mun Sun Choi; Brandon Kistler; Gretchen N Wiese; Elizabeth R Stremke; Amy J Wright; Ranjani N Moorthi; Sharon M Moe; Kathleen M Hill Gallant Journal: J Ren Nutr Date: 2018-08-11 Impact factor: 3.655
Authors: Ailema González-Ortiz; Samuel Ramos-Acevedo; Victoria Santiago-Ayala; Gabriela Gaytan; Matilde Valencia-Flores; Ricardo Correa-Rotter; Juan Jesus Carrero; Hong Xu; Ángeles Espinosa-Cuevas Journal: Front Nutr Date: 2022-07-22